Radiation guidelines for gliomas
| Autor: | Antoni, D., Feuvret, L., Biau, J., Robert, C., Mazeron, J.-J., Noël, G. |
|---|---|
| Přispěvatelé: | Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne (UCA) |
| Rok vydání: | 2021 |
| Předmět: |
Organs at Risk
Recommandations MESH: Neoplasm Grading Recommendations MESH: Antineoplastic Agents Alkylating Radiation Tolerance MESH: Magnetic Resonance Imaging MESH: Glioma Gliome anaplasique Societies Medical MESH: Aged MESH: Middle Aged MESH: Organs at Risk MESH: Radiation Tolerance Brain Neoplasms MESH: Glioblastoma MESH: Clinical Decision-Making Age Factors Glioma Middle Aged MESH: Radiation Oncology Magnetic Resonance Imaging Radiation therapy Oncology Diffuse glioma MESH: Brain Neoplasms MESH: Biomarkers Tumor France MESH: Karnofsky Performance Status Gliome diffus Glioblastome MESH: Societies Medical Clinical Decision-Making [SDV.CAN]Life Sciences [q-bio]/Cancer Biomarkers Tumor Temozolomide Humans Radiology Nuclear Medicine and imaging Karnofsky Performance Status MESH: Temozolomide Antineoplastic Agents Alkylating Radiothérapie Aged MESH: Age Factors French society for radiation oncology MESH: Humans Biologie moléculaire MESH: France Radiation Oncology Neoplasm Grading Glioblastoma Anaplastic glioma Biomarkers Société française de radiothérapie oncologique |
| Zdroj: | Cancer/Radiothérapie Cancer/Radiothérapie, 2022, 26 (1-2), pp.116-128. ⟨10.1016/j.canrad.2021.08.006⟩ |
| ISSN: | 1769-6658 1278-3218 |
| DOI: | 10.1016/j.canrad.2021.08.006⟩ |
| Popis: | International audience; Gliomas are the most frequent primary brain tumour. The proximity of organs at risk, the infiltrating nature, and the radioresistance of gliomas have to be taken into account in the choice of prescribed dose and technique of radiotherapy. The management of glioma patients is based on clinical factors (age, KPS) and tumour characteristics (histology, molecular biology, tumour location), and strongly depends on available and associated treatments, such as surgery, radiation therapy, and chemotherapy. The knowledge of molecular biomarkers is currently essential, they are increasingly evolving as additional factors that facilitate diagnostics and therapeutic decision-making. We present the update of the recommendations of the French society for radiation oncology on the indications and the technical procedures for performing radiation therapy in patients with gliomas. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect